http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2016009070-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fede5e271fe9a3788b900c0ce6e0054
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6801
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6855
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
filingDate 2015-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc6fbb59c39844631a6bec213e2c9a8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a0f0f7613e91194dbc965e654d77d93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86e55884817b490b1a8ee6fab0b256ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b021f4d309e7c8bb77e8a0bafd0f2f56
publicationDate 2016-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2016009070-A
titleOfInvention ANTIBODY-FARMACO CONJUGATES (ADC) OF DUOCARMYCINE SHOWING IMPROVED IN VIVO ANTITUMOR ACTIVITY.
abstract The present invention relates to antibody-drug (ADC) conjugates containing duocarmycin for use in the treatment of solid human tumors and hematological malignancies expressing HER2, in particular breast cancer, gastric cancer, bladder cancer, cancer of ovary, lung cancer, prostate cancer, pancreatic cancer, colorectal cancer, head and neck squamous cell cancer or osteosarcoma and acute lirifoblastic leukemia; in particular, the present invention relates to ADC containing duocarmycin for use in the treatment of solid human tumors with HER2 IHC 2+ or 1+ tissue status and negative for HER2 FISH; Advantageously, the present invention relates to ADCs containing duocarmycin for use in the treatment of triple-negative breast cancer (TNBC).
priorityDate 2014-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415817004
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115369

Total number of triples: 39.